The Rise of the Clinical Research Network: Using Technology to Connect Sites and Sponsors
Explore how integrated technology solutions can reduce inefficiencies, improve diversity, and streamline workflows in clinical research.
Explore how integrated technology solutions can reduce inefficiencies, improve diversity, and streamline workflows in clinical research.
As clinical research sites face more challenges than perhaps ever before, it’s increasingly important to provide sites with proper support
For the past two years, the clinical research industry has seen an acceleration in staff shifting to a remote, work
From the largest research centers to the smallest, sites now recognize that a clinical trial management system (CTMS) can be configured to their needs and can bring powerful efficiencies insights, and compliance to their day-to-day operations.
The most recent Cancer Center Support Grant (CCSG) guidelines released by the National Cancer Institute (NCI) include a new Core
Sites gain control with Advarra’s BYOT approach, eliminating redundant tasks and fostering efficient collaboration between research stakeholders and participants.
Selecting a clinical research training program is crucial for ensuring compliance and success. Look for engaging content, flexible delivery methods, and proven results to maximize your investment.
This eBook outlines several challenges you may face as you conduct research, and how a clinical trial management system (CTMS) can address them.
As many research organizations are becoming more patient-centric and adapting to technological advancements and remote requirements, they are re-designing the
Learn proactive strategies to overcome site-sponsor challenges and streamline processes for more successful clinical trial partnerships.
Switching from paper to eSource in clinical trials enhances data accuracy, reduces errors, and boosts organization, offering more efficient study management.
About the Advarra In Conversations With… The future of healthcare innovation hinges on research and clinical trials. Advarra sits down